• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌放疗效果及血清中性粒细胞淋巴细胞比值与炎症因子表达的研究

Study on the radiotherapy effect and serum neutral granulocyte lymphocyte ratio and inflammatory factor expression of nasopharyngeal carcinoma.

作者信息

Wu LiPing, He JianPing, Zheng YuQing, Li Yang

机构信息

Department of Otolaryngology, Huzhou Central Hospital, Huzhou, Zhejiang, 313000, China.

Department of Otolaryngology, The 910th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Quanzhou, Fujian, 362000, China.

出版信息

Open Med (Wars). 2024 Jan 16;19(1):20230842. doi: 10.1515/med-2023-0842. eCollection 2024.

DOI:10.1515/med-2023-0842
PMID:38239273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10795006/
Abstract

PURPOSE

To compare target area delineation schemes in intensity-modulated radiotherapy (IMRT) effect on patients with locally advanced nasopharyngeal carcinoma (NPC).

METHODS

A total of 88 NPC patients received IMRT and were assigned into control group ( = 44) and observation group ( = 44) based on MRI and CT imaging. In the control group, the treatment range was determined as the clinical target volume (CTV) as the gross tumor volume (GTV) + 5 mm. In the observation group, high-risk target areas CTVp1 was GTVp + 5 mm, lymphatic drainage area CTVn1 was GTVn + 5 mm, medium-risk CTVp2 was CTVp1 + 5 mm margin + the whole nasopharyngeal area, CTVn2 was CTVn1 + 5 mm. Radiotherapy treatment course was 6-8 weeks, four times a week.

RESULTS

The observation group had higher total effective rate, with fewer complications. Neutrophil lymphocyte ratio (NLR), interleukin (IL)-6, and tumor necrosis factor (TNF)-α levels were lower after radiotherapy in both groups compared to before radiotherapy, with the observation group demonstrating lower levels than the control group. The effective group exhibited lower serum NLR, IL-6, and TNF-α compared to the non-effective group. T stage, target location, serum NLR, IL-6, and TNF-α were risk factors for the effect of radiotherapy.

CONCLUSIONS

Serum NLR, IL-6, and TNF-α have predictive significance for radiotherapy effect.

摘要

目的

比较调强放射治疗(IMRT)中靶区勾画方案对局部晚期鼻咽癌(NPC)患者的影响。

方法

88例NPC患者接受IMRT治疗,根据MRI和CT影像分为对照组( = 44)和观察组( = 44)。对照组治疗范围确定为临床靶体积(CTV)即大体肿瘤体积(GTV)+ 5 mm。观察组中,高危靶区CTVp1为GTVp + 5 mm,淋巴引流区CTVn1为GTVn + 5 mm,中危CTVp2为CTVp1 + 5 mm边界+整个鼻咽区域,CTVn2为CTVn1 + 5 mm。放射治疗疗程为6 - 8周,每周4次。

结果

观察组总有效率更高,并发症更少。两组放疗后中性粒细胞淋巴细胞比值(NLR)、白细胞介素(IL)-6和肿瘤坏死因子(TNF)-α水平均低于放疗前,且观察组低于对照组。有效组血清NLR、IL-6和TNF-α水平低于无效组。T分期、靶区位置、血清NLR、IL-6和TNF-α是放疗效果的危险因素。

结论

血清NLR、IL-6和TNF-α对放疗效果具有预测意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/fa92a92df789/j_med-2023-0842-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/afb427c699c4/j_med-2023-0842-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/f6ff8b265f06/j_med-2023-0842-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/fa92a92df789/j_med-2023-0842-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/afb427c699c4/j_med-2023-0842-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/f6ff8b265f06/j_med-2023-0842-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b809/10795006/fa92a92df789/j_med-2023-0842-fig003.jpg

相似文献

1
Study on the radiotherapy effect and serum neutral granulocyte lymphocyte ratio and inflammatory factor expression of nasopharyngeal carcinoma.鼻咽癌放疗效果及血清中性粒细胞淋巴细胞比值与炎症因子表达的研究
Open Med (Wars). 2024 Jan 16;19(1):20230842. doi: 10.1515/med-2023-0842. eCollection 2024.
2
A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal Carcinoma.前瞻性 10 年观察研究:早期鼻咽癌放疗临床靶区和剂量减少。
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):672-682. doi: 10.1016/j.ijrobp.2020.03.029. Epub 2020 Apr 6.
3
Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.局部晚期鼻咽癌患者接受调强放疗时肿瘤体积的预后价值及预测阈值
Chin J Cancer. 2016 Nov 16;35(1):96. doi: 10.1186/s40880-016-0159-2.
4
Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.局部区域晚期鼻咽癌患者接受调强放射治疗时再计划的预测因素:一项前瞻性观察研究。
BMC Cancer. 2013 Nov 16;13:548. doi: 10.1186/1471-2407-13-548.
5
Induction chemotherapy reduces target volume drift in patients with locoregionally advanced nasopharyngeal carcinoma undergoing adaptive intensity-modulated radiotherapy: a retrospective cohort study.诱导化疗可减少接受自适应调强放疗的局部晚期鼻咽癌患者的靶区体积漂移:一项回顾性队列研究。
Quant Imaging Med Surg. 2023 Mar 1;13(3):1779-1791. doi: 10.21037/qims-22-776. Epub 2023 Feb 20.
6
Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.调强放射治疗与调强质子治疗在复发性鼻咽癌治疗中的剂量学比较
Med Dosim. 2022;47(1):14-19. doi: 10.1016/j.meddos.2021.07.002. Epub 2021 Aug 29.
7
The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma.正电子发射断层扫描对早期T分期鼻咽癌调强放射治疗中肿瘤原发灶勾画及剂量学结果的影响
Radiat Oncol. 2016 Aug 24;11(1):109. doi: 10.1186/s13014-016-0685-8.
8
Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.305例接受调强放射治疗的鼻咽癌患者的预后因素
Chin J Cancer. 2010 Feb;29(2):145-50. doi: 10.5732/cjc.009.10332.
9
The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.调强放疗前后中性粒细胞与淋巴细胞比值对鼻咽癌患者的预后价值
Medicine (Baltimore). 2020 Jan;99(2):e18545. doi: 10.1097/MD.0000000000018545.
10
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.调强放射治疗复发性鼻咽癌的初步经验。
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):682-7. doi: 10.1016/S0360-3016(03)01508-6.

引用本文的文献

1
The predictive value of neutrophil-to-lymphocyte ratio in the efficacy of percutaneous lumbar disc radiofrequency ablation for lumbar disc herniation.中性粒细胞与淋巴细胞比值对腰椎间盘突出症经皮腰椎间盘射频消融术疗效的预测价值
Front Pain Res (Lausanne). 2025 May 29;6:1543317. doi: 10.3389/fpain.2025.1543317. eCollection 2025.

本文引用的文献

1
The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.调强放疗前后中性粒细胞与淋巴细胞比值对鼻咽癌患者的预后价值
Medicine (Baltimore). 2020 Jan;99(2):e18545. doi: 10.1097/MD.0000000000018545.
2
Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma.鼻咽癌调强放射治疗期间靶区体积变化的剂量学影响。
Rep Pract Oncol Radiother. 2020 Jan-Feb;25(1):41-45. doi: 10.1016/j.rpor.2019.12.012. Epub 2019 Dec 16.
3
Prognostic efficacy of extensive invasion of primary tumor volume for T3-4 nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
原发肿瘤体积广泛侵犯对接受调强放疗的 T3-4 期鼻咽癌的预后疗效。
Oral Oncol. 2020 Jan;100:104478. doi: 10.1016/j.oraloncology.2019.104478. Epub 2019 Nov 20.
4
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.调强放疗治疗鼻咽癌:8 期 AJCC 分期 IVa 亚组的临床结果和失败模式。
Eur Radiol. 2020 Feb;30(2):816-822. doi: 10.1007/s00330-019-06500-5. Epub 2019 Oct 24.
5
Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma.适应性调强放疗对鼻咽癌患者中性粒细胞与淋巴细胞比值的影响。
Radiat Oncol. 2019 Aug 22;14(1):151. doi: 10.1186/s13014-019-1350-9.
6
Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives.《鼻咽癌诊断与治疗中国专家共识:基于当前实践的证据及未来展望》
Cancer Manag Res. 2019 Jul 10;11:6365-6376. doi: 10.2147/CMAR.S197544. eCollection 2019.
7
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.国际鼻咽癌放射治疗计划中剂量优先和接受标准指南。
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):567-580. doi: 10.1016/j.ijrobp.2019.06.2540. Epub 2019 Jul 2.
8
Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy.分析根治性调强放疗后鼻咽癌患者血浆 EBV-DNA 和可溶性检查点蛋白。
Biomed Res Int. 2019 May 5;2019:3939720. doi: 10.1155/2019/3939720. eCollection 2019.
9
Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.调强放疗治疗复发性鼻咽癌的长期生存和晚期并发症。
BMC Cancer. 2018 Nov 20;18(1):1139. doi: 10.1186/s12885-018-5055-5.
10
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study.阿昔替尼在鼻咽癌中的疗效、安全性和药代动力学:一项临床前和 II 期相关研究。
Clin Cancer Res. 2018 Mar 1;24(5):1030-1037. doi: 10.1158/1078-0432.CCR-17-1667. Epub 2018 Jan 4.